Twenty-five years quaternium-15 in the European baseline series: does it deserve its place there?
For allergens to be included in the European baseline series, they should have allergy rates of at least 1%. In several studies quaternium-15 had lower scores. Also, many cases of sensitization are already detected by formaldehyde contact allergy. The aim of this study was to evaluate whether quaternium-15 deserves continued inclusion in the baseline series on the basis of current criteria: 1% positive reactions, common occurrence in the environment, many relevant reactions. We used the literature survey method in this study. Only the United Kingdom has rates consistently over 1%. The mean for all other countries together and for many individual nations is lower than 1%. At least half of the reactions are already detected by formaldehyde sensitivity, which lowers rates for allergy to quaternium-15 per se (i.e. not caused or at least detected by formaldehyde sensitivity) to less than 0.6% for all countries except the United Kingdom. Neither common occurrence in the environment nor a high percentage of relevant reactions has been ascertained. It may well be argued that quaternium-15 does not deserve its place in the European baseline series and could be incorporated in a cosmetic screening series or preservative series instead. In the United Kingdom, routine testing should be continued.
de Groot
Anton C
AC
Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. antondegroot@planet.nl
Coenraads
Pieter-Jan
PJ
D017449:Dermatitis, Allergic Contact / Q000453:epidemiology* / Q000209:etiology*; D005060:Europe / Q000453:epidemiology; D006801:Humans; D008709:Methenamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D010328:Patch Tests; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D015995:Prevalence; D006113:United Kingdom / Q000453:epidemiology
D011310:Preservatives, Pharmaceutical; C018375:quaternium-15; D008709:Methenamine